Authors:
Akhtar, N
Hagan, H
Lopilato, JE
Corbett, AH
Citation: N. Akhtar et al., Functional analysis of the yeast Ran exchange factor Prp20p: in vivo evidence for the RanGTP gradient model, MOL GENET G, 265(5), 2001, pp. 851-864
Authors:
Thiede, H
Romero, M
Bordelon, K
Hagan, H
Murrill, CS
Citation: H. Thiede et al., Using a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users, J URBAN H, 78(2), 2001, pp. 264-278
Authors:
Swenson, PD
Van Geyt, C
Alexander, ER
Hagan, H
Freitag-Koontz, JM
Wilson, S
Norder, H
Magnius, LO
Stuyver, L
Citation: Pd. Swenson et al., Hepatitis B virus genotypes and HBsAg subtypes in refugees and injection drug users in the United States determined by LiPA and monoclonal EIA, J MED VIROL, 64(3), 2001, pp. 299-304
Authors:
Swenson, PD
Van Geyt, C
Alexander, ER
Hagan, H
Freitag-Koontz, JM
Wilson, S
Norder, H
Magnius, LO
Stuyver, L
Citation: Pd. Swenson et al., Hepatitis B virus genotypes and HBsAg subtypes in refugees and injection drug users in the united states determined by LiPA and monoclonal EIA, J MED VIROL, 64(3), 2001, pp. 305-311
Authors:
O'Driscoll, PT
McGough, J
Hagan, H
Thiede, H
Critchlow, C
Alexander, ER
Citation: Pt. O'Driscoll et al., Predictors of accidental fatal drug overdose among a cohort of injection drug users, AM J PUB HE, 91(6), 2001, pp. 984-987
Citation: H. Thiede et al., Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area, J URBAN H, 77(3), 2000, pp. 331-345
Citation: H. Hagan et H. Thiede, Changes in injection risk behavior associated with participation in the Seattle needle-exchange program, J URBAN H, 77(3), 2000, pp. 369-382
Authors:
Hagan, H
McGough, JP
Thiede, H
Hopkins, SG
Weiss, NS
Alexander, ER
Citation: H. Hagan et al., Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programs, J URBAN H, 77(1), 2000, pp. 103-112
Authors:
Hagan, H
McGough, JP
Thiede, H
Hopkins, S
Duchin, J
Alexander, ER
Citation: H. Hagan et al., Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors, J SUBST ABU, 19(3), 2000, pp. 247-252
Authors:
Hagan, H
McGough, JP
Thiede, H
Hopkins, SG
Alexander, ER
Citation: H. Hagan et al., Re: "Syringe exchange and risk of infection with hepatitis B and C viruses" - Five of the authors reply, AM J EPIDEM, 151(2), 2000, pp. 207-208
Authors:
Des Jarlais, DC
Paone, D
Milliken, J
Turner, CF
Miller, H
Gribble, J
Shi, QH
Hagan, H
Friedman, SR
Citation: Dc. Des Jarlais et al., Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial, LANCET, 353(9165), 1999, pp. 1657-1661
Authors:
Hagan, H
Weiss, NS
Thiede, H
Hopkins, S
McGough, JP
Alexander, ER
Citation: H. Hagan et al., Reply to "Invited commentary: Needle exchange - No help for hepatitis?" byMoss and Hahn, AM J EPIDEM, 149(3), 1999, pp. 217-218
Authors:
Des Jarlais, DC
Hagan, H
Friedman, SR
Friedmann, P
Goldberg, D
Frischer, M
Green, S
Tunving, K
Ljungberg, B
Wodak, A
Ross, M
Purchase, D
Millson, P
Myers, T
Citation: Dc. Des Jarlais et al., Preventing epidemics of HIV-1 among injecting drug users, SOC AS AIDS, 1998, pp. 183-200